StonvexLoading…
StonvexStonvexStonvexCore line items from CREG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $108.35K | $262.51K | $173.66K | $82.84K |
Operating Income | $-538.64K | $-3.02M | $-2.40M | $-2.19M |
Net Income | $-547.41K | $-2.90M | $-2.43M | $-1.24M |
EPS (Diluted) | $-0.03 | $-0.19 | $-0.16 | $-0.12 |
Total Assets | $159.65M | $157.64M | $132.97M | $132.21M |
Total Liabilities | $11.94M | $14.49M | $14.75M | $16.12M |
Cash & Equivalents | $158.79M | $40.16K | $131.88M | $131.11M |
Free Cash Flow OCF − CapEx | Not available | Not available | $63.66M | Not available |
Shares Outstanding | 22.96M | 20.95M | 24.49M | 24.49M |